Sébastien Gendarme
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sébastien Gendarme has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Antoine Gislard
Centre de Consultations de Pathologie Professionnelle, CHU de Rouen, CEDEX, 76031 Rouen, France
1 shared publication - Bénédicte Clin
Service de Santé au Travail et Pathologie Professionnelle, CHU Caen, 14000 Caen, France
1 shared publication - Christophe Paris
Service de Santé au Travail et Pathologie Professionnelle, CHU Rennes, 35000 Rennes, France
1 shared publication - Christos Chouaid
Service de Pneumologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France
1 shared publication - Fleur Delva
Epicene Team, Bordeaux Population Health Research Center, INSERM UMR 1219, Université de Bordeaux, 33000 Bordeaux, France
1 shared publication - Florence Canoui-Poitrine
Service de Santé Publique, GHU AP-HP Hôpitaux Universitaires Henri-Mondor, Créteil; UMR U955 - UPEC/Inserm U955, Faculté de Médecine de Créteil, Créteil, France; Département Masters, Faculté de Santé - UPEC, Créteil, France
1 shared publication
Latest Publications
- Open Access
Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects
Background: The National Lung Screening Trial (NLST) and NELSON study opened the debate on the relevance of lung cancer (LC) screening in subjects exposed to occupational respiratory carcinogens. This analysis reported the incremental cost-effectiveness ratios (ICER) of an organized LC screening program for an asbestos-exposed population. Methods: Using Markov modelization, individuals with asbestos exposure were either monitored without intervention or annual low-dose thoracic computed-tomography (LDTCT) scan LC screening. LC incidence came from a prospective observational cohort of subjects with occupational asbestos exposure. The intervention parameters were those of the NLST study. Utilities and LC-management costs came from published reports. A sensitivity analysis evaluated different screening strategies. Results: The respective quality-adjusted life year (QALY) gain, supplementary costs and ICER [95% confidence interval] were: 0.040 [0.010–0.065] QALY, 6900 [3700–11,800] € and 170,000 [75,000–645,000] €/QALY for all asbestos-exposed subjects; and 0.144 [0.071–0.216] QALY, 13,000 [5700–26,800] € and 90,000 [35,000–276,000] €/QALY for smokers with high exposure. When screening was based on biennial LDTCT scans, the ICER was 45,000 [95% CI: 15,000–116,000] €/QALY. Conclusions: Compared to the usual ICER thresholds, biennial LDTCT scan LC screening for smokers with high occupational exposure to asbestos is acceptable and preferable to annual scans.
Open AccessCost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects
Background: The National Lung Screening Trial (NLST) and NELSON study opened the debate on the relevance of lung cancer (LC) screening in subjects exposed to occupational respiratory carcinogens. This analysis reported the incremental cost-effectiveness ratios (ICER) of an organized LC screening program for an asbestos-exposed population. Methods: Using Markov modelization, individuals with asbestos exposure were either monitored without intervention or annual low-dose thoracic computed-tomography (LDTCT) scan LC screening. LC incidence came from a prospective observational cohort of subjects with occupational asbestos exposure. The intervention parameters were those of the NLST study. Utilities and LC-management costs came from published reports. A sensitivity analysis evaluated different screening strategies. Results: The respective quality-adjusted life year (QALY) gain, supplementary costs and ICER [95% confidence interval] were: 0.040 [0.010–0.065] QALY, 6900 [3700–11,800] € and 170,000 [75,000–645,000] €/QALY for all asbestos-exposed subjects; and 0.144 [0.071–0.216] QALY, 13,000 [5700–26,800] € and 90,000 [35,000–276,000] €/QALY for smokers with high exposure. When screening was based on biennial LDTCT scans, the ICER was 45,000 [95% CI: 15,000–116,000] €/QALY. Conclusions: Compared to the usual ICER thresholds, biennial LDTCT scan LC screening for smokers with high occupational exposure to asbestos is acceptable and preferable to annual scans.